Probably a bit early for most.

And unfortunately because of a few bashers that were constantly spewing lies non stop brought in a few longs that would counter their lies and with both it became somewhat comical and uneventful.

There was few real conversations about the company.

But now that this has started moving up, a couple of the bashers have since disappeared.

I believe this scared traders away to other boards like X and stock twits, granted I’ve heard stock twits is pretty quiet as well.

If you don’t already know Mondays and Tuesdays usually seem to be slow to start with some pullback early then late afternoon it picks up. Time will tell

With the otc it can be difficult to figure out the trends and reading charts can be difficult as well to try and predict what will happen next. Especially since this is moving now based on the company submitting the IDE some time in the second quarter.

I’m guessing volume will really start to pick up the last few days of May and continue until submitting.

All my opinions

I don’t think people understand what radiogel is all about.

These extremely low share price estimates are honestly laughable.

Lots of eyes on this that have been waiting for years for this to happen.

My opinion is that we have at least until the first week in June before the PR for submission drops.

Now that the MMs are done sucking up the 11 million shares from the offering that hit the outstanding shares count last week, this will start moving again hopefully just as good as it did on Friday maybe even better.

We have 3 weeks until June, I’m guessing the Bezinga article will finally come out with in the next 2 weeks, don’t expect anything major come out for news from this article, it’s more about getting the word out to new eyes. The second article will come out shortly after and give more details of what’s going on with isopet and vivos and maybe just maybe a better timeframe for the IDE submission.

So this can easily be sitting at around .50 cents plus before submission especially if we can get 20 to 40 percent gains a week before submitting.

This is only a FDA play right now and many are looking for the next best pharmaceuticals play in the market.

I promise you that there’s plenty of traders looking to put this in their portfolios and don’t forget brokerage firms as well

There has been no major and constant whales buying this yet as well. To me a WHALE is 250,000 shares plus.

Time will tell and obviously this is my opinion.

Unfortunately moving to the NASDAQ won’t be happening for awhile. Hopefully within the next year.

I do know that the company does want to make that move. But they aren’t even close meeting any of the requirements yet.

There is no news. The quarterly came out yesterday and that’s it.

No time frame on when the reviews will be completed.

All we know is submittal of the IDE can happen between now and the end of June.

They more than likely will not put out any updates on that end of it.

We might get lucky and maybe get a little heads up before they actually put out the PR for the submittal

Human trials, and since this is a device. The trial period is way shorter.
12-18 months plus or minus a few months

A lot depends on how many patients the FDA will require and how fast the Mayo Clinic can get them.

Very possible, there is 3 weeks left.

Now if we can just get the day traders and MMs to just let this finally go

Welcome to the wonderful world of the OTC.

We should be at a minimum 100 million dollar market cap with isopet alone, but here in otc land they just don’t give a shit.

Day traders control this now until major pr hits,

Which isn’t a bad thing, they will push the price up forcing new traders to buy in higher.

We all know major news is coming so until then the day traders control this

Buyout if it happens

1. Won’t happen until after phase 2 approval the earliest more than likely after full approval. This increases the cost of buyout exponentially considering that they will be able to get approval on several other indications fairly easily once thyroid use is approved.

2. Agree if buyout happens it will be $5 plus per share. The doctor knows what he has especially after approval.

3. Why extend the docs contract another 2yrs.

4. Dr. K doesn’t have the sole authority to sell the company.

Thanks for the post very informative and hopefully everyone sees this post, especially the new traders.

I believe this would answer a lot their questions. Especially when it comes down to the big question

What do they have left to do before they can submit.

Sounds like a lot of paperwork and crossing the Ts and dotting the I’s and making sure it’s all in order.

Depends on how big the offering is for.

The last couple of offerings had no affect on the share price. If there is a drop it won’t be much.

If this stays steady above a dollar after ide approval, the offering will be relatively small. Remember the doc only goes after exactly what he needs and he doesn’t over extend.

The other possibility here is that hopefully isopet might start bringing in real strong consistent revenue to help out. It’ll be minor but every little bit helps.

Also for an OTC the share structure is actually pretty good we are still under 400 million outstanding shares, we aren’t even halfway to the 900 million authorized shares.

But for now everything is a guessing game.

No one believed we would go from .06 to just under .20 with no news other than that they are submitting the ide in the second quarter. We are only one month into the second quarter. People are itching and trying to time it right to jump in.

In time.

With IDE approval, radiogel can start human trials.

And before you say that will take years. It will not take years.

Radiogel went the path of EFS IDE and also got approved for the BDD.


Also radiogel is a device. So in short what all of this means is that radiogel if approved could be on the market anywhere from 8-18months.

Also there’s 18 other indications/types of cancers that they are looking to use this on.

Thyroid is the first one they are looking to treat, which for difficulty of treating this is in the middle.

So once approved, there’s several other cancer types that will get approval fairly quickly.

Short term pricing

Ide submittal - .75 to 1.50 possibly higher

Ide approval - 1.25 to 5.00

Phase 1 human trials approval 1.50 - 5.00

Phase 2 human trials approval 2.00 - 5.00

Phase 3 human trials approval 5.00 plus

While all of this is going on isopet will continue to grow and good possibility they will start bringing in consistent revenue and more than likely have a dozen to two dozen clinics for animal use.

So long term if this doesn’t get bought out. This could easily be a $50 a share plus on the NASDAQ.

I’m guessing with approval this will be on the NASDAQ within the next 18 months with a price of at least 5 to 15 dollars a share.

IDE is the application for the FDA to review.

The IDE application will contain all of the testing and data collected that Radiogel has been requested to do by the FDA.

When radiogel submits the IDE application for review the FDA has 30 days to respond if no response in 30 days they have passed, but the FDA can respond sooner than 30 days as well.

Sell off was day traders taking profits and helping a much needed correction, just didn’t think it was going to drop as much as it did.

We had almost 3 straight weeks of major gains with little to no pullbacks.

I was ready for a pullback today just not that much of a pullback

Day traders taking profits, and just a decent reset before next run.

No bad news has come out.

Monthly update will be posted on new website at 3pm pacific time.

I was expecting a pullback today but not that much of a pullback.

Guess day traders over extended and needed their money back

Agree, this is trading pretty nicely with pullbacks and trading sideways at the right times

Most are not planning on selling all of their shares, they will sell some at certain levels.

1. IDE submittal
2. Hopefully IDE approval
3. Start of human trials
4. Human use approval.


Buyout won’t happen for at least a couple of years if it even happens. The doctor wants this to actually be used and not buried like some larger pharmaceutical companies will do.

Besides they pretty much have a guaranteed customer with the Mayo Clinic. They are doing the human trials and if successful I’m sure they will be the main users.

There’s probably 30 plus longs that have well over 50 million shares combined alone. Thats just the ones that post regularly on here, stocktwits, and X.

All depends on where the price is at when they drop the PR for the ide submittal.

As for when they submit the ide it will happen in the next 60days


If the trend continues and we keep gaining 25 plus percent each week before the submittal happens we could be sitting anywhere from. .30 to .70 cents a share by the time they submit the ide. As long as this trend continues.

First they have to submit the ide application which will happen this quarter.

Once submitted the fda has 30 days to pass and or deny the ide.

So in short by the company timeline there’s roughly 60 days until the end of the quarter and another possible 30 days for fda review.

So at most 90 days give or take a few days.

$100 dollars a share well we are in the otc and anything is possible.

I do agree that we could easily see $5-$10 within the year maybe even sooner.

The way this is climbing right now we could easily be sitting around .50 cents a share before the ide submittal pr drops.

This is moving very nicely, we get our run up for a few days then it pulls back some and or trades sideways for awhile

It shouldn’t matter if we are on the otc or not,

It’s a company developing a new way to attack cancer. Period. That’s what the program is about is it not.


Besides the company will have it on the market by the time they get on the NASDAQ. By then it will be too late.


Keep making excuses

You are right programs to give money for cancer research isn’t a joke.

The joke is you thinking that the moon shot program is for companies like radiogel.

It’s Biden’s way of repaying his donors by giving the grants to well established universities cancer research and big pharma.

If by some miracle radiogel gets anything from this it will be a piss in the bucket compared to what they have handed out to the universities.

On top of it, it’s been well over a year since this administration has even mentioned it.

The doc asked about it over two years ago and nothing.

Well considering they are the only ones using a gel for the delivery system. I would think that justifies them in saying they are the leaders

Radiogel won’t see a dime from it. If it was it would have happened by knowing.

They haven’t given a dime to start ups

No, I don’t think so. The moon shot program has always been a joke

The moonshot program is a joke. Only heard very little about it and what grants have been issued have gone to established cancer programs

We’ll end of month is Tuesday

Again you’re wrong, there’s been no catalyst and no reason for the share price to move other than from some longs constantly pushing radiogel onto some major traders with very large followers.

If this didn’t happen you would be right, we would still be stuck around .06 and this wouldn’t move until the ide submittal pr

Just a fyi there’s a few longs that do this two-3 times a week

It shows on Schwab.1203

It’s about getting their name out there. If you don’t like it, unfollow them on Twitter and whatever else they use to get them on peoples radar.

if you thought they would be putting more updates about the ide process. You sir are an idiot.

Oh just to disappoint you some more the the first Bezinga drop will be information about the company and what they are working on. Again they just want more people to know about the company.

No problem.

At the beginning of the year they hired full time marketing personnel. Main reason is because that for the most part there will be a lot going on month to month. This will be updated on both isopet and vivos. Obviously any major news will more than likely come out as a PR and at anytime.

They did sign a contract with Bezinga, I’m guessing will be the ones releasing the PRs when they happen, but they will also be putting out information updates on the company as well. Highly doubt this will be monthly.

Bezinga is supposed to be releasing an article hopefully this week to get the word out to more investors.

They have started putting out monthly updates, so look more towards middle of next week.

And that has what to do with a buyout, looks like absolutely nothing

All types of traders are starting to come in,
Most will be day traders so they will do what they can to manipulate the price.

And guess what, this will be happening on a regular basis, especially on Thursday/Fridays so that the day traders can get their beer money.

It’s nothing new and has zero to do with a buyout.